2023 Meeting the Challenge Summit

2023 Meeting the Challenge Summit-banner-image

2023-2024 SOCS Diversity in Dermatology Clinical Trials Task Force

Saturday, December 2, 2023

The Westin Washington, DC Downtown
999 9th Street NW
Washington, DC, 20001-4427
(202) 898-9000
Room: Rock Creek Ballroom Salons B&C

Background

As we strive for improved representation in dermatology research studies/clinical trials- there is a clear and unmet need for demographic descriptors that best describe the populations under study. At present, researchers mainly rely on race based classifications and/or the Fitzpatrick Skin Phototyping system to delineate patient populations and assess whether there are variations in disease biology, responses to therapeutic interventions and adverse reactions. However, there are significant inconsistencies across studies in both terminology and in how participants are categorized which makes it difficult to interpret and compare study data.

Objectives

To examine the use of demographic descriptors in dermatology and why they are needed.
To develop a framework for guidelines and recommendations on how to use demographic descriptors in research studies and clinical practice.
To develop strategies for implementation and dissemination to the broader dermatologic community.

Please take a minute to watch this beautiful short video that kicked off the recent Skin of Color Society Meeting the Challenge Summit: Population Descriptors in Dermatology Research Studies. As this powerful piece poetically conveys, changing the way we think about demographic descriptors can open up a more inclusive future for dermatology and science. Special thanks to the team at Ogilvy Health UK, including John McPartland, Amara Randhawa, and Simon Stacey.

View Program

Watch Recordings

Aletha Maybank, MD, MPH Chief Health Equity Officer, SVP American Medical Association

Nina G. Jablonski, PhD

Atherton Professor
Evan Pugh University Professor of Anthropology, Emerita
The Pennsylvania State University

Keynote Speaker – Nina G. Jablonski, PhD

Dr. Nina Jablonski is an anthropologist whose important contributions have rested on her research on the evolution of human skin pigmentation that accounts for why dark skin evolved under conditions of high ultraviolet radiation (UVR) in the tropics while lighter skin was favored under conditions of lower UVR nearer the poles.

Dr. Jablonski has written extensively on the fallacy of skin-color-based human races and the pervasive damage done to human societies through the persistence of race concepts. She received her A.B. in Biology at Bryn Mawr College and a Ph.D. in Anthropology at the University of Washington. She is a member of the National Academy of Sciences, the American Philosophical Society, and the American Academy of Arts & Sciences. Jablonski received an honorary doctorate from the University of Stellenbosch in South Africa in 2010 for her contribution to the worldwide fight against racism.

7:00 AM – 8:00 AM	Breakfast and Registration Check-in
8:00 AM – 8:06 AM	Welcome Remarks	Valerie M. Harvey. MD, MPH, FAAD and Valerie D. Callender, MD, FAAD
8:06 AM – 9:26 AM	Session 1: Historical Background of Race and Ethnicity in Medicine: Criticisms and Challenges
	Moderator Introductions	Valerie M. Harvey. MD, MPH, FAAD
	Race in Medicine: Lessons from Genomics	Vence L. Bonham, Jr., J.D.
	Racism, Not Race: Answers to Critical Medical Questions	Joseph L. Graves Jr., PhD
	Respect, Equity, Validity, and Reproducibility Should Go Hand in Hand in Dermatology Trials	Jenna Lester, MD, FAAD
	Moderated Q&A w/ Zoom Video Dial-In from Speaker
9:26 AM – 10:46 AM	Session 2: Advantages and Constraints of the Fitzpatrick and Skin Typing Classification Systems
	Moderator Introductions	Seemal R. Desai, MD, FAAD

	The Eumelanin Human Skin Colour Scale; A Proof-of-Concept Study	Ophelia E. Dadzie, BSc (Hons), MBBS, FRCP, DipRCPath (Dermpath), MSc (Genomic Medicine)
	Bridging Gaps: The Skin Color and Ethnicity Scale	Pearl E. Grimes, MD, FAAD
	Fitzpatrick’ Skin Phototype and Individual Typology Angle	Henry W. Lim, MD, FAAD
	Advantages and Constraints of the Fitzpatrick and Other Skin Typing Classification Systems	Susan C. Taylor, MD, FAAD
	Moderated Q&A
10:46 AM – 11:06 AM	Coffee and Tea Break
11:06 AM – 12:26 PM	Session 3: Describing Populations and the Appropriate Use of Population Descriptors: Considerations and Implications
	Moderator Introductions	Tarannum Jaleel, MD, FAAD
	Population Descriptors in Research: What to Use and Why?	Junko Takeshita, MD, PhD, FAAD
	Translating Population Descriptors into Valid and Reliable Tools and Navigating Demographic Aggregation	Suephy C. Chen, MD, FAAD
	Population Descriptors: A Regulatory Perspective	Jill Lindstrom, MD, FAAD
	Equitable Augmented Intelligence	Art Papier, MD, CEO
	Moderated Q&A
12:30 PM – 1:30 PM	Lunch and Keynote Address
12:40 PM – 1:10 PM	Rethinking Human Population Descriptors in Light of History and Evolution	Nina G. Jablonski, PhD
1:10 PM – 1:20 PM	Moderated Q&A
1:30 PM – 2:25 PM	Session 4: Stakeholder Perspectives on Current Descriptors, Areas for Improvement, and Future Considerations Panel
	Moderator Introductions	Valerie D. Callender, MD, FAAD
	Patient Voices Video	in collaboration with the Coalition of Skin Diseases
	Panel Discussion	Valerie D. Callender, MD, FAAD
	Moderated Q&A	Alexey Belkin, MD, Daphne Chan, PhD, Dirk M. Elston, MD, FAAD, and Janet Wangari Olivero, PhD
2:25 PM – 2:40 PM	Intro to Reflection Session
	Moderator Introductions	Andrew F. Alexis, MD, MPH, FAAD
		Valerie M. Harvey. MD, MPH, FAAD
		Valerie D. Callender, MD, FAAD
2:40 PM – 3:40 PM	Reflection Session: Race and Ethnicity as Categories Group Discussions and Share-Out
	Introduction	Andrew F. Alexis, MD, MPH, FAAD
	Race and Ethnicity as Categories
3:40 PM – 3:55 PM	Coffee and Tea Break
3:55 PM – 4:50 PM	Reflection Session: Use of Categories, Challenges and Implementations, and Next Steps Group Discussions and Share-Out
	Use of Categories
	Challenges and Implementations
	Next Steps
4:50 PM – 5:00 PM	Closing Remarks	Valerie M. Harvey. MD, MPH, FAAD and Valerie D. Callender, MD, FAAD
5:00 PM – 7:00 PM	Reception

SESSION 1: Historical Background of Race and Ethnicity in Medicine: Criticisms and Challenges

Valerie M. Harvey, MD, MPH, FAAD

Co-Director, Skin of Color Research Institute, Hampton University
Immediate Past President,
Co-Chair,
Diversity in Dermatology Clinical Trials Task Force,
Skin of Color Society
MODERATOR

Vence L. Bonham, Jr., J.D.

Acting Deputy Director, Office of the Director
Associate Investigator, Social and Behavioral Research Branch
National Human Genome Research Institute
National Institutes of Health

Joseph L. Graves Jr., PhD

MacKenzie Scott Endowed Professor of Biology
Director, Genomics Research and Data Science for Computation and Cloud-Computing (GRADS-4C), NIH
Associate Director, Precision Microbiome Engineering (PreMiEr), NSF Gen-4 ERC
Director, Amgen Biotech Experience, NC
Department of Biology
North Carolina A&T State University

Jenna Lester, MD, FAAD

Associate Professor
Director, Skin of Color Program UCSF
University of California, San Francisco

SESSION 2: Advantages and Constraints of the Fitzpatrick and Skin Typing Classification Systems

Seemal R. Desai, MD, FAAD

President, Medical Director,
Innovative Dermatology
Clinical Assistant Professor of Dermatology,
UT Southwestern
MODERATOR

Ophelia E. Dadzie, BSc (Hons), MBBS, FRCP, DipRCPath (Dermpath), MSc (Genomic Medicine)

Consultant Dermatologist,
The Hillingdon Hospitals NHS Foundation
Chair of the Dermatological Lexicon Group,
British Association of Dermatologists

Pearl E. Grimes, MD, FAAD

Director, The Grimes Center for Medical and Aesthetic Dermatology
Director, The Vitiligo & Pigmentation Institute of Southern California

Henry W. Lim, MD, FAAD

Former Chair
Department of Dermatology
Detroit, MI, USA

Susan C. Taylor, MD, FAAD

Bernett L. Johnson Endowed Professor
Director, Skin of Color Research Fellowship
Vice Chair for Diversity, Equity and Inclusion, Department of Dermatology
Perelman School of Medicine at the University of Pennsylvania
Past Vice-President American Academy of Dermatology (2020-2021)
Founder, Skin of Color Society

SESSION 3: Describing Populations and the Appropriate Use of Population Descriptors: Considerations and Implications

Tarannum Jaleel, MD

Assistant Professor of Dermatology,
Duke Dermatology,
Duke University School of Medicine
MODERATOR

Suephy Chen, MD, FAAD

Professor of Dermatology
Chair of the Department of Dermatology
Duke University School of Medicine

Jill Lindstrom, MD, FAAD

Senior Physician
Office of Immunology and Inflammation
US Food and Drug Administration

Art Papier, MD, CEO

CEO and Co-Founder
VisualDx
Associate Professor of Dermatology and Medical Informatics
University of Rochester

Junko Takeshita, MD, PhD, MSCE

Penn Medicine Assistant Professor of Dermatology
Penn Medicine Assistant Professor of Epidemiology in Biostatistics and Epidemiology

SESSION 4: Stakeholder Perspectives on Current Descriptors, Areas for Improvement, and Future Considerations Panel

Valerie D. Callender, MD, FAAD

Professor of Dermatology,
Howard University College of Medicine
President, American Dermatological Association
Medical Director, Callender Dermatology & Cosmetic Center
Founder & Senior Medical Director,
Callender Center for Clinical Research, LLC
Co-Chair,
Diversity in Dermatology Clinical Trials Task Force, Skin of Color Society
MODERATOR

Alexey Belkin, MD

Program Director,
National Institute of Arthritis,
Musculoskeletal and Skin Diseases,
National Institutes of Health

Daphne Chan, PhD

Head of Dermatology Medical Affairs
Janssen Immunology

Dirk M. Elston, MD, FAAD

Editor, JAAD
Professor and Chairman,
Department of Dermatology &
Dermatology Surgery,
Medical University of South Carolina

Janet Wangari Olivero, PhD

Assistant Vice President
L’Oréal Research & Innovation North America

SESSION 5: Reflection Session

Andrew F. Alexis, MD, MPH, FAAD

Vice-Chair for Diversity and Inclusion
Department of Dermatology
Professor of Clinical Dermatology
Weill Cornell Medical College
President, Skin of Color Society (2023-2024)
MODERATOR

Valerie D. Callender, MD, FAAD

Valerie M. Harvey, MD, MPH, FAAD

Co-Director, Skin of Color Research Institute, Hampton University
Immediate Past President,
Co-Chair,
Diversity in Dermatology Clinical Trials Task Force,
Skin of Color Society

Reserve your room at The Westin Washington, DC Downtown!

Kindly book your reservation through the SOCS Room Block by November 10, 2023 here: https://book.passkey.com/go/SOCS

The Westin Washington, DC Downtown
999 9th Street NW
Washington, DC, 20001-4427
(202) 898-9000

Registration closed on Monday, November 20, 2023 at 2:00 PM CT. If you are unable to meet the deadline, kindly reach out to Janice Ayarzagoitia, our Program Manager, at jayarzagoitia@skinofcolorsociety.org or Alyssa Antun, Membership & Registration Manager, at aantun@skinofcolorsociety.org for further assistance.

Registration fee: $100.00 USD

2023-2024 SOCS Diversity in Dermatology Clinical Trials Task Force

Co-Chairs:
Valerie D. Callender, MD, FAAD
Valerie M. Harvey, MD, MPH, FAAD

Members:
Stafford G. Brown, III, MS
Cheryl Marie Burgess, MD, FAAD
Angel Byrd, MD, PhD
Caryn Cobb, BA
Roxana Daneshjou, MD, PhD, FAAD
Seemal R. Desai, MD, FAAD
Pearl E. Grimes, MD, FAAD
Candrice R. Heath, MD, FAAD
Tarannum Jaleel, MD
Amy McMichael, MD, FAAD
Yvette Miller-Monthrope, MD, MSc, FRCPC, FAAD
Chidubem A. V. Okeke, BS
Hema A. Sundaram, MD, FAAD
Junko Takeshita, MD, PhD, MSCE, FAAD
Susan C. Taylor, MD, FAAD
Jonathan S. Weiss, MD, FAAD
Jane Y. Yoo, MD, MPP, FAAD

Valerie M. Harvey, MD, MPH, FAAD

Co-Director, Skin of Color Research Institute, Hampton University
Immediate Past President,
Co-Chair,
Diversity in Dermatology Clinical Trials Task Force,
Skin of Color Society

Valerie D. Callender, MD, FAAD

Sponsorship

Support from industry involved in dermatology research studies will ensure key stakeholder representation in the summit. Sponsored participation is by invitation only.

If your company is involved in dermatology research studies, and you wish to participate, please contact Kimberly Miller, Executive Director, at kmiller@skinofcolorsociety.org for more information.

Our Sponsors

The 2023 Meeting the Challenge Summit is made possible with thanks to the support of the following sponsors:

CHAMPION

Janssen / J&J | L’Oréal Research & Innovation

ALLY

Bristol Myers Squibb | Eli Lilly, Inc. | Incyte Corporation

PARTNER

Abbvie | Arcutis Biotherapeutics | Google Health | Sanofi / Regeneron

PURPOSE

The purpose of the SOCS Summit Resident Member Travel Grant is to enable dermatology residents to attend the 2023 Meeting the Challenge Summit being held on Saturday, December 2, 2023 in Washington, DC. Grants are intended for travel, room and board as needed to attend the meeting.

The Diversity in Dermatology in Clinical Trials Task Force will only consider budgeted costs for travel, room, and board.

8 travel grant awards are available of up to $1,000 USD each.

Application Opens: September 1, 2023
Entry Deadline: September 21, 2023, at 11:59AM CT
*The system will automatically prevent entry submission after the deadline.
Awardees announced: End of September
*An email will be sent to the awardees on or around September 28, 2023.

APPLICANT ELIGIBILITY

This program is reserved to current Skin of Color Society Resident Members.

TRAVEL GRANT REQUIREMENTS FOR RECIPIENTS

Lodging: Overnight accommodation must be booked via the SOCS provided room-block registration at Westin Washington DC Downtown Hotel in Washington, DC.
Completion of short surveys (post-event).
A one-page written report by the awardee summarizing the experience and what was learned is required after attending the Summit, for possible publication on the SOCS website, annual meeting report, and social media.

SUBMIT YOUR APPLICATION

Go to https://skinofcolor.awardsplatform.com/
Login or create a new user account
Select ‘SOCS DiDCT Travel Grant’ from the dropdown menu under ‘Category’
Complete all other initial required fields (i.e., Entrant, Title)
Click ‘Save + Next’ to proceed to complete the application form.

Please note that extensions will not be granted for this opportunity.

8/02/23 Update: The application cycle for this travel grant will open September 1, 2023.